
Health
Campaigners make final appeal to HSE over Skyclarys drug
Campaigners advocating for those affected by Friedreich's Ataxia have again appealed to the HSE to approve the Skyclarys treatment ahead of a final decision next week.

Campaigners advocating for those affected by Friedreich's Ataxia have again appealed to the HSE to approve the Skyclarys treatment ahead of a final decision next week.